Medical Marijuana, Inc. Portfolio Company Kannalife, Inc. Publishes New Research on CBD and Chemotherapy-Induced Peripheral Neuropathy

Related posts

Cannabis Investor Merida Capital Surpasses $50 Million in Assets

Editor

Lender 420 is Providing Financial Solutions to Cannabis Businesses

Editor

Canopy Growth Corp Records 3rd Quarter Revenue of $21.7M

Editor

Leave a Comment